不同制造商植入物全髋关节置换术的长期生存率
基于新西兰关节登记处108,613例初次全髋关节置换术数据,排除植入少于50例的组合后纳入99,732例(90.5%),其中不匹配组24,537例(24.6%)。匹配组翻修率0.72/100组件年,不匹配组0.69/100组件年(P=0.049);排除金属对金属或陶瓷对金属轴承后两组翻修率无差异(P=0.742)。17年生存率在各时间点95%置信区间内重叠,不匹配组牛津髋关节评分有小幅统计学显著改善。
要点
- 不匹配组翻修率0.69/100组件年,匹配组0.72/100组件年(P=0.049)。
- 排除金属对金属或陶瓷对金属轴承后,两组翻修率无差异(P=0.742)。
- 17年生存率在各时间点95%置信区间内重叠,不匹配组牛津髋关节评分小幅改善。
核心结论
- 新西兰关节登记处数据证实,全髋关节置换术中使用不匹配组件对结局无不良影响。
研究设计与样本
- 分析全国性关节登记处新西兰关节登记处(NZJR)数据,评估不匹配植入物全髋关节置换术的长期结局。
主要发现
- NZJR共记录108,613例初次全髋关节置换术,排除植入少于50例的组合后纳入99,732例(90.5%),不匹配组24,537例(24.6%)。
- 匹配组3434例(4.6%)需翻修,翻修率0.72/100组件年;不匹配组1078例(4.4%)需翻修,翻修率0.69/100组件年(P=0.049)。
- 匹配组中金属对金属或陶瓷对金属轴承比例过高;排除这些植入物后,两组翻修率无差异(匹配组4.0%翻修,0.65/100组件年;不匹配组4.3%翻修,0.67/100组件年;P=0.742)。
- 生存分析显示匹配组件和不匹配组件的17年生存率在所有时间点均在95%置信区间内。
- 不匹配组牛津髋关节评分较匹配组有小幅统计学显著改善。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Total hip arthroplasty (THA) can be performed using either femoral and acetabular components provided by the same manufacturer (matched components) or components from different manufacturers (unmatched components). We hypothesized that there would be no difference in outcomes following the use of unmatched compared to matched components. METHODS: Data from a nationwide joint registry, the New Zealand Joint Registry (NZJR), were analyzed to assess long-term outcomes of using unmatched implants in THA. RESULTS: The NZJR has recorded a total of 108,613 primary THAs. We excluded combinations with less than 50 implantations, leaving 99,732 arthroplasties (90.5%). The unmatched group consisted of 24,537 (24.6%) THAs. Revision procedures were required in 3434 (4.6%) of the matched group, at a rate of 0.72/100 component years and 1078 (4.4%) of the unmatched group, a rate of 0.69/100 component years (P = .049). THAs with metal-on-metal or ceramic-on-metal bearings were overrepresented in the matched group. When analysis was repeated with these implants excluded, there was no longer a difference in revision rate between groups (4.0% revisions, 0.65/100 component years and 4.3% revisions, 0.67/100 component years [P = .742]). Survival analysis showed 17-year survival for matched components and unmatched to be within 95% confidence intervals at all time points. There was a small, statistically significant improvement in Oxford Hip Scores for the unmatched group compared with the matched group. CONCLUSION: Data from the NZJR confirm that the use of unmatched components in THA has no adverse effect on outcomes.
引用
- Taylor JW, Frampton C, Rothwell AG, et al. Long-Term Survival of Total Hip Arthroplasty Using Implants From Different Manufacturers. J Arthroplasty. 2017. PMID: 29102074. doi:10.1016/j.arth.2017.09.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。